Internal Medicine · Raleigh, NC
NPI
1730133604
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
6
Medicare group memberships
Hospitals
0
Hospital affiliations
4505 Fair Meadows Ln Ste 101
Raleigh, NC, 27607
Phone (919) 787-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
766 services
Medicare patients, 2024
84
Average age 69
Drug cost, 2024
$2.5M
11,278 prescriptions
Company payments, 2025
$1,924
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chawki A Lahoud was code 99214 (office e&m - established), 209 times for 71 patients. In total Chawki A Lahoud billed 766 services in 40 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 209 | 71 | $75.86 | $16K |
| 82962 Clinical Chemistry | Office | 90 | 38 | $3.21 | $289 |
| 36415 Venipuncture Blood Collection | Office | 73 | 48 | $8.65 | $631 |
| 99213 Office E&M - Established | Office | 51 | 37 | $58.41 | $2,979 |
| 81002 Clinical Chemistry | Office | 34 | 25 | $3.41 | $116 |
| 93000 Electrocardiogram | Office | 30 | 24 | $9.14 | $274 |
| 96372 Injection Administration | Office | 30 | 16 | $7.09 | $213 |
| 99212 Office E&M - Established | Office | 19 | 17 | $36.28 | $689 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 17 | 17 | $121.17 | $2,060 |
| G0008 Administration of influenza virus vaccine | Office | 12 | 12 | $28.60 | $343 |
By year: 2022 $30K for 898 services; 2023 $30K for 761 services; 2024 $27K for 766 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 90 | 38 | $3.21 | $289 |
| 36415 Venipuncture Blood Collection | 73 | 48 | $8.65 | $631 |
| 81002 Clinical Chemistry | 34 | 25 | $3.41 | $116 |
Medicare prescription drug claims, 2024
In 2024, the drug Chawki A Lahoud prescribed most often to Medicare patients was Gabapentin, with 491 prescriptions and refills. In total Chawki A Lahoud wrote 11,278 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 491 | 931 | 115 | $6,994 |
| Linzess Linaclotide | 460 | 1,005 | 113 | $509K |
| Atorvastatin Calcium Generic | 445 | 1,049 | 112 | $2,721 |
| Amlodipine Besylate Generic | 388 | 830 | 93 | $1,473 |
| Omeprazole Generic | 373 | 783 | 106 | $4,493 |
| Metformin Hcl Generic | 346 | 927 | 90 | $1,522 |
| Meloxicam Generic | 265 | 295 | 90 | $765 |
| Metoprolol Succinate Generic | 246 | 565 | 58 | $2,412 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 235 | 266 | 54 | $6,030 |
| Losartan Potassium Generic | 233 | 506 | 57 | $1,388 |
| Fluticasone Propionate Generic | 232 | 300 | 57 | $3,076 |
| Duloxetine Hcl Generic | 223 | 405 | 53 | $3,079 |
| Farxiga Dapagliflozin Propanediol | 205 | 365 | 41 | $199K |
| Lisinopril Generic | 201 | 476 | 59 | $906 |
| Ozempic Semaglutide | 181 | 276 | 33 | $258K |
Brand drugs: 2,474 claims; generic drugs: 8,717 claims; opioid claims: 177.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chawki A Lahoud $1,924 ($1,924 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $379.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 11 | $379 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $330 |
| Novo Nordisk Inc NVO | 12 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $176 |
| Medtronic, Inc. MDT | 1 | $170 |
| Lilly USA, LLC LLY | 4 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $137 |
| Axsome Therapeutics, Inc. AXSM | 1 | $95.4 |
| GlaxoSmithKline, LLC. GSK | 3 | $59.26 |
| Abbvie Inc. ABBV | 2 | $56.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.